CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

KROS Q2 Earnings Miss as Revenues Fall to Zero, Pipeline in Focus

EarningsNegative
AI Analysis

Summary

Kronos Bio reported Q2 2026 earnings that missed expectations with revenues falling to zero. The company's pipeline remains a key focus area for investors.

Financial Highlights

Revenue

zero

Importance:4/10
Sentiment:
-0.80
earningsrevenue_misspipelineQ2_2026
Related Companies

Read the original article

Published by yahoo_finance on August 4, 2026 2:43 PM

Read Original